First principle: build vs stabilise
- Estrogen = proliferation. It thickens the endometrium (proliferative phase), thins cervical mucus (sperm‑friendly), and drives tissue growth.
- Progesterone = secretory transformation + stabilisation. It matures the estrogen‑primed endometrium, thickens mucus (sperm‑hostile), and holds the lining. Its withdrawal precipitates menstruation.
| State | Endometrium | Bleeding consequence |
|---|---|---|
| Estrogen then progesterone, then withdrawal | proliferative → secretory → shed | orderly cyclical menses |
| Unopposed estrogen (anovulation) | continued proliferation, unstable | irregular bleeding; hyperplasia → carcinoma risk 🚩 |
| Estrogen deficiency (menopause/POI) | atrophic | amenorrhoea; GSM |
The predictive rule that saves lives
This one rule generates: why anovulatory PCOS needs endometrial protection (Concept 18), why estrogen‑only HRT is contraindicated with an intact uterus (Concept 22), and why unopposed‑estrogen states are the risk profile for endometrial cancer (Concept 37).
Discriminators
- A secretory endometrium (or a positive mid‑luteal progesterone) is proof ovulation occurred. A persistently proliferative endometrium suggests anovulation.
Pitfalls
- Giving estrogen to a woman with a uterus without a progestogen — a predictable, preventable oncogenic error. 🚩
Pearls
- 🎯 Progesterone withdrawal = menses; progesterone absence = unopposed‑estrogen risk.
- 🩺 In any chronically anovulatory woman, ask: what is protecting this endometrium?
Next → Now watch the axis run a full cycle — follicular selection to luteal rescue (Concept 8).